3' education - Nov. 26, 2014 - VBWG Chicago - Michael J Koren
Dr Michael J Koren MD, Jacksonville, FL, USA, shares his rationale for targeting PCSK9, based on epidemiology and recent clinical developments and discusses implications for future lipid management
Share this page with your colleagues and friends: